IL319271A - תכשירים למסירה אוראלית - Google Patents

תכשירים למסירה אוראלית

Info

Publication number
IL319271A
IL319271A IL319271A IL31927125A IL319271A IL 319271 A IL319271 A IL 319271A IL 319271 A IL319271 A IL 319271A IL 31927125 A IL31927125 A IL 31927125A IL 319271 A IL319271 A IL 319271A
Authority
IL
Israel
Prior art keywords
methacrylic acid
dosage form
iii
poly
ethyl acrylate
Prior art date
Application number
IL319271A
Other languages
English (en)
Inventor
Aktham Aburub
Siyuan Huang
Jennifer Marie Walker
Original Assignee
Lilly Co Eli
Aktham Aburub
Siyuan Huang
Jennifer Marie Walker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Aktham Aburub, Siyuan Huang, Jennifer Marie Walker filed Critical Lilly Co Eli
Publication of IL319271A publication Critical patent/IL319271A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL319271A 2022-08-29 2023-08-28 תכשירים למסירה אוראלית IL319271A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263373776P 2022-08-29 2022-08-29
PCT/US2023/072968 WO2024050289A1 (en) 2022-08-29 2023-08-28 Compositions for oral delivery

Publications (1)

Publication Number Publication Date
IL319271A true IL319271A (he) 2025-04-01

Family

ID=88147307

Family Applications (1)

Application Number Title Priority Date Filing Date
IL319271A IL319271A (he) 2022-08-29 2023-08-28 תכשירים למסירה אוראלית

Country Status (16)

Country Link
EP (1) EP4580608A1 (he)
JP (1) JP2025530743A (he)
KR (1) KR20250057847A (he)
CN (1) CN120112280A (he)
AR (1) AR130332A1 (he)
AU (1) AU2023333905A1 (he)
CA (1) CA3266547A1 (he)
CL (1) CL2025000555A1 (he)
CO (1) CO2025002297A2 (he)
CR (1) CR20250068A (he)
DO (1) DOP2025000043A (he)
IL (1) IL319271A (he)
MX (1) MX2025002326A (he)
PE (1) PE20251068A1 (he)
TW (1) TW202423472A (he)
WO (1) WO2024050289A1 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119792493A (zh) * 2024-12-04 2025-04-11 中山大学附属第三医院 一种负载替西帕肽的介孔聚多巴胺纳米粒及其制备方法与应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
EP2389388B1 (en) 2009-01-22 2017-03-08 KeyBioscience AG Treatment for obesity
TWI689515B (zh) 2012-05-03 2020-04-01 丹麥商西蘭製藥公司 Ｇｉｐ-ｇｌｐ-１雙重促效劑化合物及方法
HUE037663T2 (hu) 2013-11-14 2018-09-28 Keybioscience Ag Kalcitonin mimetikumok betegségek és rendellenességek kezelésére
TW201625671A (zh) 2014-09-04 2016-07-16 諾佛 儂迪克股份有限公司 新穎澱粉素及降鈣素受體促效劑
JOP20200119A1 (ar) 2015-01-09 2017-06-16 Lilly Co Eli مركبات مساعد مشترك من gip وglp-1
AR104932A1 (es) 2015-06-22 2017-08-23 Lilly Co Eli Compuestos co-agonistas del glucagón y péptido-1 similar al glugacón (glp-1)
TWI809515B (zh) 2017-12-21 2023-07-21 美商美國禮來大藥廠 腸促胰島素(incretin)類似物及其用途
CR20210040A (es) 2018-07-23 2021-02-12 Lilly Co Eli Compuestos coagonistas de gip/glp1
TWI865836B (zh) 2018-11-01 2024-12-11 美商美國禮來大藥廠 蛋白質酪胺酸-酪胺酸類似物及其使用方法
TWI764209B (zh) 2019-08-01 2022-05-11 美商美國禮來大藥廠 Gipr促效劑化合物
BR112022012514A2 (pt) * 2019-12-27 2022-09-06 Evelo Biosciences Inc Formas de dosagem sólidas que contêm bactérias e vesículas extracelulares microbianas
CN116419750A (zh) 2020-09-07 2023-07-11 西普鲁梅有限公司 改进的glp-1受体激动剂的药物制剂
AR124295A1 (es) 2020-12-18 2023-03-15 Lilly Co Eli Agonistas duales del receptor de amilina y calcitonina y usos de los mismos

Also Published As

Publication number Publication date
DOP2025000043A (es) 2025-03-31
CR20250068A (es) 2025-03-27
CA3266547A1 (en) 2024-03-07
JP2025530743A (ja) 2025-09-17
WO2024050289A1 (en) 2024-03-07
AU2023333905A1 (en) 2025-03-20
CO2025002297A2 (es) 2025-03-06
CN120112280A (zh) 2025-06-06
TW202423472A (zh) 2024-06-16
MX2025002326A (es) 2025-04-02
AR130332A1 (es) 2024-11-27
CL2025000555A1 (es) 2025-05-09
PE20251068A1 (es) 2025-04-09
EP4580608A1 (en) 2025-07-09
KR20250057847A (ko) 2025-04-29

Similar Documents

Publication Publication Date Title
KR101858797B1 (ko) 히드로모르폰 및 날록손을 포함하는 제약 조성물
CN1420767A (zh) 含托特罗定的药物制剂及其应用
US20150164893A1 (en) Pharmaceutical formulations for carrier-mediated transport statins and uses thereof
CN111728953A (zh) 一种托法替布或其盐的缓释制剂及其制备方法
AU2024205201A1 (en) Amantadine compositions, preparations thereof, and methods of use
IL319271A (he) תכשירים למסירה אוראלית
US11957686B2 (en) Compositions for delivery of reboxetine
AU2005262576B2 (en) Oral delivery of peptide pharmaceutical compositions
US20050277691A1 (en) Pravastatin pharmaceutical formulations and methods of their use
US20210015823A1 (en) Compositions for delivery of reboxetine
AU2020353381A1 (en) Therapeutic formulations and uses thereof
EP3209286B1 (en) Novel pharmaceutical formulation
WO2004096186A1 (en) Extended release venlafaxine tablet formulation
US20150250734A1 (en) Stable pharmaceutical compositions of saxagliptin or salts thereof
EP3025707A1 (en) A multilayer tablet comprising metformin and pioglitazone
CA2433915A1 (en) Improved controlled release oral dosage form
US11759471B2 (en) Modified release pharmaceutical composition and method for the treatment of mental disorders
CN119055750A (zh) 利拉鲁肽二甲双胍组合物
CN119055751A (zh) 胰岛素二甲双胍组合物
AU2003285739B2 (en) Extended release venlafaxine tablet formulation
EP1905431A1 (en) Pravastatin pharmaceutical formulations and methods of their use
US20070148241A1 (en) Use of an intermediate for controlling the release profile of an oral formulation of a medicament
HK1141228B (en) Isosorbide mononitrate double-rate osmotic pump type controlled-release formulation and preparation method thereof
ZA200601644B (en) Treatment of gastroparesis and nonulcer dyspepsia with gaba B agonists